Close
Explore more Centres, Projects and Groups
Welcome
Welcome Banner

Tight K

Tight K is a study investigating the strategy of controlling potassium levels after cardiac surgery.

Usual care is to maintain potassium levels above 4.5 mEq/L following cardiac surgery. This study will compare usual care against maintaining potassium levels above 3.6 mEq/L.

Bottom Content
About

Tight K is a pragmatic, multicentre, non-inferiority randomised clinical trial based in the UK. The study will investigate whether a strategy of maintaining potassium levels at ≥3.6 mEq/L is non-inferior to maintaining at ≥4.5 mEq/L on the occurrence of new onset atrial fibrillation after cardiac surgery.

1684 patients who are undergoing isolated CABG surgery will be recruited into the study.

Who we are

The study is managed by the Clinical Trials Unit at the London School of Hygiene & Tropical Medicine, and funded by the British Heart Foundation.

The sponsor of the study is Barts Health NHS Trust. 

Resources

All our study documentation can be accessed here if you want to find out more about how to participate in this research.

Publications

A list of our publications can be accessed here.

About
About Tight K 2 columns
About Tight K 2 columns left
Paragraph

Tight K is the first appropriately powered non-inferiority multicentre randomised trial of a strategy of 'relaxed' potassium supplementation versus a strategy of 'tight' potassium supplementation, which is defined as standard of care. The routine maintenance of serum [K+] ≥4.5 mEq/L is of unproven efficacy, may be unpleasant or hazardous for patients, and is costly. The findings will have important consequences for patients and clinicians, regardless of whether or not potassium supplementation is found to be non-inferior for the prevention of AF after cardiac surgery. A survey of practice patterns in Europe and North America suggests that there is genuine equipoise, with 67% of caregivers practising in Europe reporting that their institution has a protocol for maintaining high-normal serum potassium levels after cardiac surgery. So one in three do not.

The Tight K Trial will set out to test the hypothesis that AF after cardiac surgery will be no more common after CABG surgery when serum potassium levels are maintained ≥3.6 mEq/L as when they are maintained ≥4.5 mEq/L.

Inclusion criteria

  1. Scheduled to have isolated CABG surgery
  2. Patient in sinus rhythm

Exclusion criteria

  1. Age less than 18 years
  2. Previous history of Atrial Fibrillation, Atrial Flutter and/or Atrial Tachyarrhythmia
  3. Pre-operative high-degree atrioventricular (AV) block (defined as Mobitz type 2 second degree AV block or complete heart block)
  4. Pre-operative serum [K+] greater than 5.5 mEq/L
  5. Current or previous use of medication for the purposes of cardiac rhythm management
  6. Dialysis-dependent end-stage renal failure
  7. Concurrent patient involvement in another clinical study assessing cardiac rhythm post-operative interventions
  8. Unable to provide informed consent

If you are a patient interested in taking part in the study, you can contact the research team at your local hospital to discuss this further.

Who We Are
Team Block
Photo of Ben OBrien

Ben O’Brien

CHIEF INVESTIGATOR

Richard Evans

Senior Manager of the Clinical Trials Unit
Main contact

Kiran Bal

Assistant Trial Manager
For queries about setup

Laura Van Dyck

Data Manager
Queries about data
Resources
Resources Tight K 2 columns
Resources Tight K 2 columns left paragraph
Paragraph

Tight K Trial protocol

Tight K Trial patient information sheet

Tight K Trial consent form

Tight K Trial Holter monitor training

Tight K Holter monitor training video (below). This video describes the process for applying the Holter monitors to Tight K trial participants.

Publications
Publications
E-bulletins
Tight K e-bulletins 2 columns
Tight K e-bulletins 2 columns left paragraph
Paragraph

This page is under construction.